Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
Markers of serotonin synapses in entire temporal lobe and frontal and temporal neocortex were examined for changes in Alzheimer's disease by use of both neurosurgical and autopsy samples. Uptake of [3H]serotonin, binding of [3H]imipramine, and content of indolamines were all significantly reduc...
Auteurs principaux: | Bowen, D, Allen, S, Benton, J, Goodhardt, M, Haan, E, Palmer, A, Sims, N, Smith, C, Spillane, J, Esiri, M, Neary, D, Snowdon, J, Wilcock, G, Davison, A |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1983
|
Documents similaires
-
Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
par: Pearce, B, et autres
Publié: (1984) -
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.
par: Bowen, D, et autres
Publié: (2008) -
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
par: Francis, P, et autres
Publié: (1985) -
Complementary roles of serotonergic and cholinergic systems in decisions about when to act
par: Khalighinejad, N, et autres
Publié: (2022) -
Caveolin-3 differentially orchestrates cholinergic and serotonergic constriction of murine airways
par: M. Keshavarz, et autres
Publié: (2018-05-01)